The global brain biomarkers market is poised for remarkable growth, fueled by the escalating prevalence of neurological disorders and rapid technological advancements. A recent market analysis reveals that the sector, valued at USD 8,516.7 million in 2023, is projected to reach USD 11,557.3 million by 2033, growing at a Compound Annual Growth Rate (CAGR) of …
Tag Archives: Brain Biomarkers Market
Global Brain Biomarkers Market Set for Significant Growth, Projected to Reach USD 11,557.3 Million by 2033
The global brain biomarkers market is on the verge of substantial expansion, driven by the increasing prevalence of neurological disorders and rapid advancements in technology. According to recent market analysis, the industry is anticipated to be valued at USD 8,516.7 million in 2023. With a robust growth trajectory, the market is expected to achieve a …
Neuroscience Renaissance: Brain Biomarkers Market Role in Propelling the US$ 11.5 Billion by 2032 and Revolutionizing Neurological Disorder Treatments | FMI
The Brain Biomarkers Market has emerged as a dynamic and promising field within the realm of medical diagnostics and neuroscience research. Brain biomarkers, which are measurable indicators found in various biological substances such as blood, cerebrospinal fluid, and even brain tissue, offer valuable insights into the physiological and pathological processes occurring in the brain. These …
Brain Biomarkers Market Overview 2022 to 2032 | By Qiagen N.V., Nexus-DX, Natus Medical, GE Healthcare
The global Brain Biomarkers market demand is expected to grow at a 14.3% CAGR between 2022 and 2032. It’s expected to be worth US$ 8.3 billion in 2022 and US$ 11.5 billion in 2032. Brain biomarker sales will be driven in the future by the increased prevalence of neurological illnesses such as brain tumours, migraines, …